Life Science Tools, MDx M&A Flat in 2011; Improvement Ahead? | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – The number of mergers and acquisitions in the genomics tools and molecular diagnostics markets in 2011 was flat compared to 2010 as a strong start to the year fizzled out in the second half.

Despite the late-year lull, some experts are predicting a rebound in M&A activity over the next couple of years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.